Deeptech Connect 2025: Major Trends in Healthcare and Biotechnology Innovation

Deeptech Connect, organized by the SATT Network, is a must-attend event for France’s innovation and technology transfer ecosystem, and took place on November 4, 2025, in Paris.

‍

Pauline, an innovation consultant at Dynergie, explored the eight themed villages at the trade show, highlighting promising solutions, particularly in the healthcare sector.

Our insights in video format

Check out our two-part video series now, hosted by Pauline, a Ph.D. in biology specializing in health and an innovation financing consultant at Dynergie.

‍

With five years of academic research dedicated to the preclinical development of innovative therapies and human disease models derived from stem cells (resulting in four scientific publications), she has been offering her expertise to companies since 2024 to help them leverage their R&D&I efforts through tax incentives (JEI, CIR, CII, CICO, CIC, and certifications) and public grants (BPI, ADEME).

Early diagnosis: A Key Challenge in E-Health

One of the central themes of Deeptech Connect 2025 was Diagnostics & e-Health. As Pauline points out, the common goal of the projects presented is speed: diagnosing conditions as early as possible.

‍

SoQut Imaging is a perfect example of this race against time. The company is developing software capable of transforming standard MRI images and measurements into diagnostic information as accurate as a biopsy.

‍

We congratulate them; in fact, their pitch won an award in the Diagnostic & e-Health village.

‍

Biotechnology Takes on the Challenge of Incurable Diseases

Pauline also took an interest in the Biotechnology Village, a sector where there is a strong commitment to developing therapeutic strategies for diseases that have so far been incurable, such as certain cancers or brain disorders.

‍

The development of treatments for the brain is hindered by the blood-brain barrier: a system that protects against pathogens and toxins, but also prevents therapies from reaching the brain. To overcome this obstacle, Harmonix is developing a gene therapy approach encapsulated in gas microbubbles.

‍

Through the use of ultrasound, they are able to deliver their therapeutic payload across the barrier. 

‍

In summary 

The innovations showcased at Deeptech Connect 2025—ranging from software-based medical imaging to therapeutic nanotechnologies—underscore the vital role of technology transfer in turning basic research into practical solutions.

‍

As Mehdi Gmar (Deputy Director General for Innovation at the CNRS) pointed out, supporting public research is key to fostering the deep-tech gems that will shape the solutions of tomorrow, particularly in the healthcare sector.

‍

At Dynergie, we are proud to support these deep-tech innovators who are turning scientific discoveries into industrial and medical realities.

‍